NCT03860714

Brief Summary

This study intends to evaluate the relationship between urinary albumin/creatinine ratio and postoperative neurocognitive impairment in elderly non-cardiac surgery patients. The results of the study are to identify risk factors, screen high-risk populations to improve clinical evidence, early detection and early treatment.And reducing the burden of PNCD on patients and their families, hospitals and public resources.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 4, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2020

Completed
Last Updated

March 4, 2019

Status Verified

February 1, 2019

Enrollment Period

12 months

First QC Date

February 22, 2019

Last Update Submit

February 27, 2019

Conditions

Keywords

Postoperative Cognitive DysfunctionDeliriumUACR

Outcome Measures

Primary Outcomes (7)

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    before discharge from PACU

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    morning of the 1st day after surgery

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    afternoon of the 1st day after surgery

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    morning of the 2st day after surgery

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    afternoon of the 2st day after surgery

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    morning of the 3st day after surgery

  • Confusion Assessment Method(CAM)

    Confusion Assessment Method to measure delirium

    afternoon of the 3st day after surgery

Secondary Outcomes (16)

  • Quality of Recovery Score - 40 (QoR-40)

    1 day before surgery(baseline)

  • Quality of Recovery Score - 40 (QoR-40)

    1 day after surgery

  • Numerical Rating Scale(NRS)

    before discharge from PACU

  • Numerical Rating Scale(NRS)

    morning of the 1st day after surgery

  • Numerical Rating Scale(NRS)

    afternoon of the 1st day after surgery

  • +11 more secondary outcomes

Other Outcomes (6)

  • blood Albumin levels

    before surgery(baseline)

  • blood Hemoglobin content

    before surgery(baseline)

  • blood Alanine aminotransferase (ALT) levels

    before surgery(baseline)

  • +3 more other outcomes

Study Arms (1)

study group

400 Male and female patients undergoing non-cardiac surgery at the Affiliated Hospital of Xuzhou Medical University \[Jiangsu China\].We do the neuropsychological tests,MMSE,CCI,CDR,QoR-40,GDS,CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),NRS once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

Diagnostic Test: Neuropsychological tests

Interventions

We do the neuropsychological tests, Mini-Mental score examination (MMSE),Charlson Comorbidity Index(CCI),Clinical Dementia Rating(CDR),Quality of Recovery Score - 40 (QoR-40),Geriatric Depression Scale (GDS),CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),Numerical Rating Scale(NRS)once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

study group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We included 400 patients undergoing non-cardiac surgery at the affiliated hospital of Xuzhou Medical University.

You may qualify if:

  • Non-cardiac surgery patients;
  • Age is greater than or equal to 60 years old; ③Han Nationality, mother tongue is chinese;
  • ④The MMSE score:Illiteracy is greater than or equal to 17 points, primary school is greater than or equal to 20 points, higher secondary school is more than 24 points;
  • ⑤The people signed informed consent.

You may not qualify if:

  • The diagnosis of preoperative delirium;
  • The diagnosis Unstable hypertension(Such as:pheochromocytoma or aortic dissection); ③Severe chronic obstructive pulmonary disease or congestive heart failure; ④Severe liver and kidney dysfunction;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia of the Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

urine and blood

MeSH Terms

Conditions

Postoperative Cognitive ComplicationsDelirium

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental DisordersConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor-in-charge of Anesthetist

Study Record Dates

First Submitted

February 22, 2019

First Posted

March 4, 2019

Study Start

January 1, 2019

Primary Completion

December 30, 2019

Study Completion

May 30, 2020

Last Updated

March 4, 2019

Record last verified: 2019-02

Locations